Pfizer scraps one weight loss drug in race to develop Ozempic rival 0 26.06.2023 16:36 JPost.com The company's shares fell 3.5% in volatile premarket trading on Monday as Pfizer said it would stop developing its therapy lotiglipron. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
